EXPO

Exponent, Inc., together with its subsidiaries, is a science and engineering consulting firm that provides solutions to complex problems. The Company’s segments include Engineering and Other Scientific and Environmental and Health. The Engineering and Other Scientific segment is a broad service group providing technical consulting in different practices, primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a wide range of consulting services relating to environmental hazards and risks and their impact on both human health and the environment. It serves clients in chemicals, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation and other sectors of the economy. The Company’s service offerings are provided on a project-by-project basis.

Wall Street analysts forecast EXPO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EXPO is 76.00 USD with a low forecast of 76.00 USD and a high forecast of 76.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Exponent Inc revenue for the last quarter amounts to 137.07M USD, increased 9.58 % YoY.

Exponent Inc. EPS for the last quarter amounts to 0.55 USD, increased 10.00 % YoY.

Exponent Inc (EXPO) has 1168 emplpoyees as of December 15 2025.

Today EXPO has the market capitalization of 3.67B USD.